scholarly journals Association of nitrotyrosine with oxidised LDL, C- reactive protein and malondialdehyde in prehypertensive and hypertensive patients

2019 ◽  
Vol 12 (2) ◽  
pp. 56-61
Author(s):  
Balu Mahendran K ◽  
◽  
Santhi T ◽  
Keyword(s):  
C Reactive Protein ◽  
Hypertensive Patients ◽  
Oxidised Ldl ◽  
Reactive Protein

scholarly journals Relationships between high-sensitive C-reactive protein and markers of arterial stiffness in hypertensive patients. Differences by sex

2012 ◽  
Vol 12 (1) ◽  
Author(s):  
Manuel A Gomez-Marcos ◽  
Jose I Recio-Rodríguez ◽  
Maria C Patino-Alonso ◽  
Cristina Agudo-Conde ◽  
Leticia Gomez-Sanchez ◽  
...  
Keyword(s):  
Arterial Stiffness ◽  
C Reactive Protein ◽  
Hypertensive Patients ◽  
Reactive Protein

scholarly journals Effects of combined statin and ACE inhibitor therapy on endothelial function and blood pressure in essential hypertension - a randomised double-blind, placebo controlled crossover study

2019 ◽  
Vol 20 (3) ◽  
pp. 147032031986889 ◽  
Author(s):  
Piotr Ruszkowski ◽  
Anna Masajtis-Zagajewska ◽  
Michał Nowicki
Keyword(s):  
Blood Pressure ◽  
Essential Hypertension ◽  
Angiotensin Converting Enzyme ◽  
Endothelial Function ◽  
Enzyme Inhibitor ◽  
Converting Enzyme ◽  
C Reactive Protein ◽  
Double Blind ◽  
Hypertensive Patients ◽  
Reactive Protein

Background: The aim of this study was to compare the influence of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors on endothelial function and blood pressure in patients with essential hypertension on long-term angiotensin-converting enzyme inhibitor therapy. Method: The study was designed as a prospective, double-blind, randomised, placebo controlled, crossover clinical trial. Twenty patients with essential hypertension were treated with an angiotensin-converting enzyme inhibitor; the control group included 10 healthy subjects. Hypertensive patients received in random order 80 mg of fluvastatin daily or placebo for 6 weeks. The following parameters were assessed at baseline and after each treatment period: serum lipids, flow-mediated vasodilation, activity of von Willebrand factor, concentration of vascular endothelial growth factor, C-reactive protein and 24-hour blood pressure profile. Results: Hypertensive patients did not differ from healthy subjects with respect to age, body mass and biochemical parameters, with the exception of C-reactive protein, which was higher in hypertensive patients ( P=0.02). After statin therapy, low-density lipoprotein cholesterol ( P<0.0001), C-reactive protein ( P=0.03), von Willebrand factor ( P=0.03) and vascular endothelial growth factor ( P<0.01) decreased and flow-mediated vasodilation improved ( P<0.001). Statins had no significant effect on blood pressure. Conclusions: Statins added to angiotensin-converting enzyme inhibitors may improve endothelial function and ameliorate inflammation independently of blood pressure.

scholarly journals Endothelial dysfunction and C‐reactive protein predict the incidence of heart failure in hypertensive patients

2020 ◽  
Author(s):  
Raffaele Maio ◽  
Maria Perticone ◽  
Edoardo Suraci ◽  
Angela Sciacqua ◽  
Giorgio Sesti ◽  
...  
Keyword(s):  
Heart Failure ◽  
Endothelial Dysfunction ◽  
C Reactive Protein ◽  
Hypertensive Patients ◽  
Reactive Protein

scholarly journals C-reactive protein, atherosclerosis and kidney function in hypertensive patients

2005 ◽  
Vol 19 (7) ◽  
pp. 521-526 ◽  
Author(s):  
M J Hommels ◽  
A J A M van der Ven ◽  
A A Kroon ◽  
A G H Kessels ◽  
M P van Dieijen-Visser ◽  
...  
Keyword(s):  
Kidney Function ◽  
C Reactive Protein ◽  
Hypertensive Patients ◽  
Reactive Protein

MICROALBUMINURIA IS CLOSELY ASSOCIATED WITH INCREASED PLASMA LEVELS OF C-REACTIVE PROTEIN IN UNTREATED ESSENTIAL HYPERTENSIVE PATIENTS

2004 ◽  
Vol 22 (Suppl. 2) ◽  
pp. S217
Author(s):  
C. Tsioufis ◽  
K. Dimitriadis ◽  
M. Toutouza ◽  
D. Chatzis ◽  
C. Vasiliadou ◽  
...  
Keyword(s):  
Plasma Levels ◽  
C Reactive Protein ◽  
Hypertensive Patients ◽  
Reactive Protein

AUGMENTED PLASMA LEVELS OF C-REACTIVE PROTEIN IN UNTREATED ESSENTIAL HYPERTENSIVE PATIENTS

2004 ◽  
Vol 22 (Suppl. 2) ◽  
pp. S327-S328
Author(s):  
K. Dimitriadis ◽  
C. Tsioufis ◽  
M. Toutouza ◽  
D. Chatzis ◽  
E. Taxiarchou ◽  
...  
Keyword(s):  
Plasma Levels ◽  
C Reactive Protein ◽  
Hypertensive Patients ◽  
Reactive Protein
Sign in / Sign up

Export Citation Format

Share Document